Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

Clinical trial NCT01139008 · COMPLETED

Trial details

NCT number: NCT01139008
Sponsor: Galderma R&D
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Skin Manifestations

Start date: 2010-06-01
Primary completion: 2010-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.